Inhalation of peptide-loaded nanoparticles improves heart failure

• Autor(a) principal: Miragoli, Michele
• Data de Publicação: 2018
• Outros Autores: Ceriotti, Paola, Iafisco, Michele, Vacchiano, Marco, Salvarani, Nicolò, Carullo, Pierluigi, Ramírez-Rodríguez, Gloria Belén, Fernandes Patrício, Tatiana Marisa, Degli Esposti, Lorenzo, Rossi, Francesca, Ravanetti, Francesca, Pinelli, Silvana, Alinovi, Rossella, Erreni, Marco, ROSSI, Stefano, Condorelli, Gianluigi, Post, Heiner, TAMPIERI, ANNA, Catalucci, Daniele
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.8/8927

Peptides are highly selective and efficacious for the treatment of cardiovascular and other diseases. However, it is currently not possible to administer peptides for cardiac-targeting therapy via a noninvasive procedure, thus representing scientific and technological challenges. We demonstrate that inhalation of small (<50 nm in diameter) biocompatible and biodegradable calcium phosphate nanoparticles (CaPs) allows for rapid translocation of CaPs from the pulmonary tree to the bloodstream and to the myocardium, where their cargo is quickly released. Treatment of a rodent model of diabetic cardiomyopathy by inhalation of CaPs loaded with a therapeutic mimetic peptide that we previously demonstrated to improve myocardial contraction resulted in restoration of cardiac function. Translation to a porcine large animal model provides evidence that inhalation of a peptide-loaded CaP formulation is an effective method of targeted administration to the heart. Together, these results demonstrate that inhalation of biocompatible tailored peptide nanocarriers represents a pioneering approach for the pharmacological treatment of heart failure.